Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

Bibiana Bielekova, Nancy Richert, Thomas Howard, Gregg Blevins, Silva Markovic-Plese, Jennifer McCartin, Joseph A. Frank, Jens Würfel, Joan Ohayon, Thomas A. Waldmann, Henry F. McFarland, Roland Martin

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)17565
Number of pages1
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number50
DOIs
StatePublished - Dec 14 2004
Externally publishedYes

ASJC Scopus subject areas

  • Genetics
  • General

Cite this